Current EU rules restrict access to new, potentially life-saving cancer treatments in children

IMG_0636by Jackie Turner, Macmillan Principal Pharmacist Oncology & Haematology

Around 1,600 children are diagnosed with cancer in the UK every year.

But is there enough paediatric research to allow more testing of potentially life-saving cancer drugs?  

Currently, the EU Regulations allow pharmaceutical companies to opt out of children’s trials if a new drug is intended for an adult cancer that does not occur in children.

What does this mean? Read more Current EU rules restrict access to new, potentially life-saving cancer treatments in children